#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Heavy menstrual bleeding Macular telangiectasia Herpes simplex Extra-osseous Ewing's sarcoma recurrent Pancreatic carcinoma metastatic Chronic graft versus host disease in liver Arrhythmogenic right ventricular dysplasia Craniopharyngioma Chronic myeloid leukaemia (in remission) Cryoglobulinaemia Autoimmune demyelinating disease Endometrial adenocarcinoma Choroidal dystrophy Oesophageal adenocarcinoma Immunodeficiency More trials…

    Learn about Rare Diseases

    Idiopathic inflammatory myopathy – Life with Disease Wiskott-Aldrich syndrome – Basic Information Breast angiosarcoma – Treatment Angiosarcoma recurrent Synovial sarcoma metastatic – Treatment Methylmalonic acidaemia – Life with Disease Mantle cell lymphoma – Trials in Disease Leiomyosarcoma – Diagnostics Cystic fibrosis – Diagnostics Biotinidase deficiency – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Midazolam Sufentanil Citrate Regn7075 Motixafortide Haloperidol Decanoate Indacaterol Maleate Ipatasertib Isotretinoin The-630 Doxycycline Hyclate Taminadenant Prednisolone Sodium Succinate Polatuzumab Vedotin OMECAMTIV MECARBIL Azd8421 Morf-057 Disulfiram Sulpiride GSKVX000000048111 Canakinumab More therapies…

    Learn about Your Condition

    Venous thrombosis Brain cancer metastatic Naevus flammeus Neurodegenerative disorder Primary biliary cholangitis Deafness Ocular myasthenia Neuromuscular scoliosis Eclampsia Antithrombin III deficiency Meniere's disease Factor IX deficiency Large cell lung cancer Tubulointerstitial nephritis Cognitive disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Bp 96031, Rouen, 76031, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of N-acetylcysteine and prednisolone combination versus extended prednisolone treatment in patients with severe alcoholic hepatitis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hepatitis alcoholic
    Investigated Drugs:
    • Acetylcysteine
    • Prednisolone Metasulfobenzoate Sodium
    • Prednisolone
    France

  • Study of bevacizumab and trifluridine combination given bi-weekly to reduce severe neutropenia in patients with metastatic colorectal cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal adenocarcinoma
    Investigated Drugs:
    • Bevacizumab
    • Trifluridine
    France

  • Study of Gemcitabine with Paclitaxel versus Standard Chemotherapy Combination for Patients with Borderline Resectable Pancreatic Cancer Based on Gene Analysis

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Irinotecan Hydrochloride Trihydrate
    • Fluorouracil
    • Folinic Acid
    France

  • Study of Probenecid for Controlling Cluster Seizures in Patients with Focal Epilepsy During Pre-surgical Video-EEG Monitoring

    Recruiting

    2 1 1
    France

  • Study comparing oral and injectable nefopam in patients with acute rheumatologic pain to evaluate how the medication is processed by the body

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pain
    Investigated Drugs:
    • Nefopam Hydrochloride
    France

  • Long-term safety and effectiveness study of ritlecitinib in children with severe alopecia areata who completed previous trials B7981027 or B7981031

    Recruiting

    3 1
    Czechia France Italy Poland Spain

  • Study comparing tadalafil with ambrisentan versus tadalafil alone in newly diagnosed patients with pulmonary arterial hypertension who have cardiovascular conditions

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Ambrisentan
    • Tadalafil
    France

  • Study of hypertonic saline solution and mannitol to improve recovery in patients with traumatic brain injury and high risk of intracranial hypertension

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Craniocerebral injury
    Investigated Drugs:
    • Mannitol
    • Sodium Chloride
    France

  • Study of Nucresiran in Adults with Transthyretin Amyloidosis with Cardiomyopathy to Evaluate its Effects on Survival and Heart Problems

    Recruiting

    3 1
    Investigated Diseases:
    • Cardiomyopathy
    Austria Belgium Czechia Denmark France Germany +12

  • Study comparing ALG-000184 with tenofovir disoproxil in untreated adults with chronic hepatitis B virus infection

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chronic hepatitis B
    Investigated Drugs:
    • ALG-000184
    • Tenofovir Disoproxil
    Bulgaria France Italy Romania Spain
Previous Page
1 2 3 4 5 6 … 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!